Core outcomes set for trials in people with coronavirus disease 2019
<p><strong>Objectives: </strong></p> <p>The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous and of uncertain patient relevance, limiting their applicability for clinical decision-making. The aim of this workshop was to establish a cor...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Lippincott, Williams and Wilkins
2020
|
| _version_ | 1826270512762847232 |
|---|---|
| author | Tong, A Elliott, JH Azevedo, LC Baumgart, A Bersten, A Cervantes, L Chew, DP Cho, Y Cooper, T Crowe, S Douglas, IS Evangelidis, N Flemyng, E Hannan, E Horby, P Howell, M Lee, J Liu, E Lorca, E Lynch, D Marshall, JC Gonzalez, AM McKenzie, A Manera, KE McLeod, C Mehta, S Mer, M Morris, AC Nseir, S Povoa, P Reid, M Sakr, Y Shen, N Smyth, AR Snelling, T Strippoli, GF Teixeira-Pinto, A Torres, A Turner, T Viecelli, AK Webb, S Williamson, PR Woc-Colburn, L Zhang, J Craig, JC COVID-19-Core Outcomes Set (COS) Workshop Investigators |
| author_facet | Tong, A Elliott, JH Azevedo, LC Baumgart, A Bersten, A Cervantes, L Chew, DP Cho, Y Cooper, T Crowe, S Douglas, IS Evangelidis, N Flemyng, E Hannan, E Horby, P Howell, M Lee, J Liu, E Lorca, E Lynch, D Marshall, JC Gonzalez, AM McKenzie, A Manera, KE McLeod, C Mehta, S Mer, M Morris, AC Nseir, S Povoa, P Reid, M Sakr, Y Shen, N Smyth, AR Snelling, T Strippoli, GF Teixeira-Pinto, A Torres, A Turner, T Viecelli, AK Webb, S Williamson, PR Woc-Colburn, L Zhang, J Craig, JC COVID-19-Core Outcomes Set (COS) Workshop Investigators |
| author_sort | Tong, A |
| collection | OXFORD |
| description | <p><strong>Objectives: </strong></p>
<p>The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous and of uncertain patient relevance, limiting their applicability for clinical decision-making. The aim of this workshop was to establish a core outcomes set for trials in people with suspected or confirmed coronavirus disease 2019.</p>
<p><strong>Design: </strong></p>
<p>Four international online multistakeholder consensus workshops were convened to discuss proposed core outcomes for trials in people with suspected or confirmed coronavirus disease 2019, informed by a survey involving 9,289 respondents from 111 countries. The transcripts were analyzed thematically. The workshop recommendations were used to finalize the core outcomes set.</p>
<p><strong>Setting: </strong></p>
<p>International.</p>
<p><strong>Subjects: </strong></p>
<p>Adults 18 years old and over with confirmed or suspected coronavirus disease 2019, their family members, members of the general public and health professionals (including clinicians, policy makers, regulators, funders, researchers).</p>
<p><strong>Interventions: </strong></p>
<p>None.</p>
<p><strong>Measurements: </strong></p>
<p>None.</p>
<p><strong>Main Results: </strong></p>
<p>Six themes were identified. “Responding to the critical and acute health crisis” reflected the immediate focus on saving lives and preventing life-threatening complications that underpinned the high prioritization of mortality, respiratory failure, and multiple organ failure. “Capturing different settings of care” highlighted the need to minimize the burden on hospitals and to acknowledge outcomes in community settings. “Encompassing the full trajectory and severity of disease” was addressing longer term impacts and the full spectrum of illness (e.g. shortness of breath and recovery). “Distinguishing overlap, correlation and collinearity” meant recognizing that symptoms such as shortness of breath had distinct value and minimizing overlap (e.g. lung function and pneumonia were on the continuum toward respiratory failure). “Recognizing adverse events” refers to the potential harms of new and evolving interventions. “Being cognizant of family and psychosocial wellbeing” reflected the pervasive impacts of coronavirus disease 2019.</p>
<p><strong>Conclusions: </strong></p>
<p>Mortality, respiratory failure, multiple organ failure, shortness of breath, and recovery are critically important outcomes to be consistently reported in coronavirus disease 2019 trials.</p> |
| first_indexed | 2024-03-06T21:41:58Z |
| format | Journal article |
| id | oxford-uuid:483a2041-7731-4df7-8c81-8390b1b543b9 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:41:58Z |
| publishDate | 2020 |
| publisher | Lippincott, Williams and Wilkins |
| record_format | dspace |
| spelling | oxford-uuid:483a2041-7731-4df7-8c81-8390b1b543b92022-03-26T15:24:49ZCore outcomes set for trials in people with coronavirus disease 2019Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:483a2041-7731-4df7-8c81-8390b1b543b9EnglishSymplectic ElementsLippincott, Williams and Wilkins2020Tong, AElliott, JHAzevedo, LCBaumgart, ABersten, ACervantes, LChew, DPCho, YCooper, TCrowe, SDouglas, ISEvangelidis, NFlemyng, EHannan, EHorby, PHowell, MLee, JLiu, ELorca, ELynch, DMarshall, JCGonzalez, AMMcKenzie, AManera, KEMcLeod, CMehta, SMer, MMorris, ACNseir, SPovoa, PReid, MSakr, YShen, NSmyth, ARSnelling, TStrippoli, GFTeixeira-Pinto, ATorres, ATurner, TViecelli, AKWebb, SWilliamson, PRWoc-Colburn, LZhang, JCraig, JCCOVID-19-Core Outcomes Set (COS) Workshop Investigators<p><strong>Objectives: </strong></p> <p>The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous and of uncertain patient relevance, limiting their applicability for clinical decision-making. The aim of this workshop was to establish a core outcomes set for trials in people with suspected or confirmed coronavirus disease 2019.</p> <p><strong>Design: </strong></p> <p>Four international online multistakeholder consensus workshops were convened to discuss proposed core outcomes for trials in people with suspected or confirmed coronavirus disease 2019, informed by a survey involving 9,289 respondents from 111 countries. The transcripts were analyzed thematically. The workshop recommendations were used to finalize the core outcomes set.</p> <p><strong>Setting: </strong></p> <p>International.</p> <p><strong>Subjects: </strong></p> <p>Adults 18 years old and over with confirmed or suspected coronavirus disease 2019, their family members, members of the general public and health professionals (including clinicians, policy makers, regulators, funders, researchers).</p> <p><strong>Interventions: </strong></p> <p>None.</p> <p><strong>Measurements: </strong></p> <p>None.</p> <p><strong>Main Results: </strong></p> <p>Six themes were identified. “Responding to the critical and acute health crisis” reflected the immediate focus on saving lives and preventing life-threatening complications that underpinned the high prioritization of mortality, respiratory failure, and multiple organ failure. “Capturing different settings of care” highlighted the need to minimize the burden on hospitals and to acknowledge outcomes in community settings. “Encompassing the full trajectory and severity of disease” was addressing longer term impacts and the full spectrum of illness (e.g. shortness of breath and recovery). “Distinguishing overlap, correlation and collinearity” meant recognizing that symptoms such as shortness of breath had distinct value and minimizing overlap (e.g. lung function and pneumonia were on the continuum toward respiratory failure). “Recognizing adverse events” refers to the potential harms of new and evolving interventions. “Being cognizant of family and psychosocial wellbeing” reflected the pervasive impacts of coronavirus disease 2019.</p> <p><strong>Conclusions: </strong></p> <p>Mortality, respiratory failure, multiple organ failure, shortness of breath, and recovery are critically important outcomes to be consistently reported in coronavirus disease 2019 trials.</p> |
| spellingShingle | Tong, A Elliott, JH Azevedo, LC Baumgart, A Bersten, A Cervantes, L Chew, DP Cho, Y Cooper, T Crowe, S Douglas, IS Evangelidis, N Flemyng, E Hannan, E Horby, P Howell, M Lee, J Liu, E Lorca, E Lynch, D Marshall, JC Gonzalez, AM McKenzie, A Manera, KE McLeod, C Mehta, S Mer, M Morris, AC Nseir, S Povoa, P Reid, M Sakr, Y Shen, N Smyth, AR Snelling, T Strippoli, GF Teixeira-Pinto, A Torres, A Turner, T Viecelli, AK Webb, S Williamson, PR Woc-Colburn, L Zhang, J Craig, JC COVID-19-Core Outcomes Set (COS) Workshop Investigators Core outcomes set for trials in people with coronavirus disease 2019 |
| title | Core outcomes set for trials in people with coronavirus disease 2019 |
| title_full | Core outcomes set for trials in people with coronavirus disease 2019 |
| title_fullStr | Core outcomes set for trials in people with coronavirus disease 2019 |
| title_full_unstemmed | Core outcomes set for trials in people with coronavirus disease 2019 |
| title_short | Core outcomes set for trials in people with coronavirus disease 2019 |
| title_sort | core outcomes set for trials in people with coronavirus disease 2019 |
| work_keys_str_mv | AT tonga coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT elliottjh coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT azevedolc coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT baumgarta coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT berstena coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT cervantesl coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT chewdp coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT choy coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT coopert coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT crowes coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT douglasis coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT evangelidisn coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT flemynge coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT hannane coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT horbyp coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT howellm coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT leej coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT liue coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT lorcae coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT lynchd coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT marshalljc coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT gonzalezam coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT mckenziea coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT manerake coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT mcleodc coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT mehtas coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT merm coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT morrisac coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT nseirs coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT povoap coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT reidm coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT sakry coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT shenn coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT smythar coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT snellingt coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT strippoligf coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT teixeirapintoa coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT torresa coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT turnert coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT viecelliak coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT webbs coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT williamsonpr coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT woccolburnl coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT zhangj coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT craigjc coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 AT covid19coreoutcomessetcosworkshopinvestigators coreoutcomessetfortrialsinpeoplewithcoronavirusdisease2019 |